Welcome to CDC stacks | Neutralizing Antibodies in Survivors of Sin Nombre and Andes Hantavirus Infection - 16028 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Neutralizing Antibodies in Survivors of Sin Nombre and Andes Hantavirus Infection
  • Published Date:
    Jan 2006
  • Source:
    Emerg Infect Dis. 12(1):166-168.
Filetype[PDF-139.52 KB]


Details:
No Related Documents.
You May Also Like:
  1. Incidence Rate for Hantavirus Infections without Pulmonary Syndrome, Panama
    Personal Author:
    Armien, Blas; Pascale, Juan M.; Munoz, Carlos; Lee, Sang-Joon; Choi, Kook L.; Avila, Mario; Broce, Candida; Armien, Anibal G.; Gracia, Fernando; Hjelle, Brian; Koster, Frederick;
    Published:
    Oct 2011
    Source:
    Emerg Infect Dis. 17(10):1936-1939.
    Description:
    During 2001-2007, to determine incidence of all hantavirus infections, including those without pulmonary syndrome, in western Panama, we conducted 11 communitywide surveys. Among 1,129 persons, antibody prevalence was 16.5%-60.4%. Repeat surveys of 4...
    File Type:
    Filetype[PDF - 229.71 KB]
  2. Identification and care of patients with Hantavirus disease
    Personal Author:
    Knust, Barbara; Mertz, Gregory; Harkins, Michelle;
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.). Office of Public Health Preparedness and Response. Division of Emergency Operations.. National Center for Zoonotic, Vector-Borne and Enteric Diseases (U.S.).
    Published:
    June 30, 2016
    Series:
    COCA Conference Call
    Description:
    July 5, 2016, 1:00 - 2:00 pm ET : Hantavirus infection in the United States can cause severe and life-threatening illness, requiring rapid assessment, presumptive diagnosis, and high-level supportive care of respiratory and cardiac functions. Hantavi...
    File Type:
    Filetype[PDF - 3.22 MB]
  3. First Human Isolate of Hantavirus (Andes virus) in the Americas
    Personal Author:
    Galeno, Hector; Mora, Judith; Villagra, Eliecer; Fernandez, Jorge; Hernandez, Jury; Mertz, Gregory J.; Ramirez, Eugenio;
    Published:
    Jul 2002
    Source:
    Emerg Infect Dis. 8(7):657-661.
    Description:
    We isolated Andes virus (formal name: Andes virus [ANDV], a species in the genus Hantavirus), from serum of an asymptomatic 10-year-old Chilean boy who died 6 days later of hantavirus pulmonary syndrome (HPS). The serum was obtained 12 days after his...
    File Type:
    Filetype[PDF - 1018.28 KB]
  4. Vascular events in viral hemorrhagic fevers: a comparative study of dengue and hantaviruses
    Personal Author:
    Srikiatkhachorn, Anon; Spiropoulou, Christina F.;
    Published:
    Mar 13 2014
    Source:
    Cell Tissue Res. 355(3):621-633.
    Description:
    Viral hemorrhagic diseases are a group of systemic viral infections with worldwide distribution and are significant causes of global mortality and morbidity. The hallmarks of viral hemorrhagic fevers are plasma leakage, thrombocytopenia, coagulopathy...
    File Type:
    Filetype[PDF - 637.96 KB]
  5. Sin nombre virus (SNV) Ig isotype antibody response during acute and convalescent phases of hantavirus pulmonary syndrome.
    Personal Author:
    Bostik, P.; Winter, J.; Ksiazek, T. G.; Rollin, P. E.; Villinger, F.; Zaki, S. R.; Peters, C. J.; Ansari, A. A.;
    Published:
    2000 Mar-Apr
    Source:
    Emerg Infect Dis. 6(2):184-187.
    Description:
    Serum samples from 22 hantavirus pulmonary syndrome (HPS) patients were tested for Sin Nombre virus (SNV)-reactive antibodies. In the acute phase of HPS, 100% and 67% of the samples tested positive for SNV-specific immunoglobulin (Ig) M and IgA, resp...
    File Type:
    Filetype[PDF - 175.76 KB]